{"organizations": [], "uuid": "78991484d8420257bec335cff35c8f05534b26e2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 1}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-helsinn-group-and-mei-pharmas-prac/brief-helsinn-group-and-mei-pharmas-pracinostat-receives-orphan-drug-designation-from-european-medicines-agency-idUSFWN1P6062", "country": "US", "domain_rank": 408, "title": "BRIEF-Helsinn Group and MEI Pharma's Pracinostat receives orphan drug designation from European Medicines Agency", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-11T10:11:00.000+02:00", "replies_count": 0, "uuid": "78991484d8420257bec335cff35c8f05534b26e2"}, "author": "", "url": "https://www.reuters.com/article/brief-helsinn-group-and-mei-pharmas-prac/brief-helsinn-group-and-mei-pharmas-pracinostat-receives-orphan-drug-designation-from-european-medicines-agency-idUSFWN1P6062", "ord_in_thread": 0, "title": "BRIEF-Helsinn Group and MEI Pharma's Pracinostat receives orphan drug designation from European Medicines Agency", "locations": [], "entities": {"persons": [], "locations": [{"name": "pracinostat", "sentiment": "none"}], "organizations": [{"name": "mei pharma", "sentiment": "negative"}, {"name": "brief-helsinn group", "sentiment": "negative"}, {"name": "european medicines agency", "sentiment": "negative"}, {"name": "mei pharma inc", "sentiment": "none"}, {"name": "european medicines agency reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 11, 2018 / 8:12 AM / Updated an hour ago BRIEF-Helsinn Group and MEI Pharma's Pracinostat receives orphan drug designation from European Medicines Agency Reuters Staff 1 Min Read \nJan 11 (Reuters) - Mei Pharma Inc: \n* HELSINN GROUP AND MEI PHARMA ANNOUNCE THAT PRACINOSTAT HAS RECEIVED ORPHAN DRUG DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-11T10:11:00.000+02:00", "crawled": "2018-01-11T10:30:22.030+02:00", "highlightTitle": ""}